Israel Englander Catalent, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $2.69 Million - $3.9 Million	83,700 Added 1350.0%	89,900 $4.04 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $5.59 Million - $11.8 Million	-175,600 Reduced 96.59%	6,200 $268,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $4.63 Million - $7.56 Million	101,800 Added 127.25%	181,800 $11.9 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $2.65 Million - $5.18 Million	-64,000 Reduced 44.44%	80,000 $3.6 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $9.41 Million - $14.7 Million	130,000 Added 928.57%	144,000 $10.4 Million

510

150M

510K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.